We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanogen Expands Partnership with HandyLab for IVD Testing

By LabMedica International staff writers
Posted on 05 Mar 2009
Nanogen, Inc. (San Diego, CA, USA) has expanded its partnership with HandyLab, Inc. (Ann Arbor, MI, USA) with a licensing and supply agreement for use of the company's proprietary Minor Groove Binder (MGB) probe technology and synthetic nucleic acid chemistries, including dyes and quenchers, for in vitro diagnostic (IVD) testing. HandyLab will receive a nonexclusive license to market, sell, and distribute polymerase chain reaction (PCR) test kits utilizing Nanogen's technology for use on HandyLab's Jaguar System and other HandyLab systems. Terms of the agreement include an upfront license fee and a commitment to supply HandyLab with Nanogen's PCR products.

The licensing agreement marks the expansion of an already established partnership. In 2008, the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) awarded a U.S. $10.4 million, two-year contract to Nanogen for the development of a multianalyte molecular diagnostic assay for Influenza. The Influenza test is being developed for use with the HandyLab microfluidic real-time PCR Raider instrument.

Nanogen's MGB technology is licensed broadly in various fields and is an integral component in thousands of PCR-probe products. The company's products include molecular diagnostic kits and reagents, and kits for rapid point-of-care testing.

HandyLab develops, manufactures, and sells novel molecular diagnostic products based on its microfluidic real-time PCR and nucleic acid extraction technologies. The company's systems reduce the time, complexity, and cost of nucleic acid testing while simultaneously improving the quality of results for infectious disease, genetic, and other molecular diagnostic tests.

Related Links:

Nanogen, Inc.
HandyLab, Inc.



New
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Unit-Dose Packaging solution
HLX
New
H.pylori DNA Extraction Kit
Savvygen Stool NA Extraction Kit
New
DNA topoisomerase I ELISA
Anti-Scl-70 ELISA Test

Latest Molecular Diagnostics News

Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer

POC Sepsis Test Delivers Fast, Accurate and User-Friendly Results in Critical Care Settings

Experimental Blood Test Improves Detection of Early-Stage Pancreatic Cancer